Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	559.47	628.11	879.52	526.42	339.15	438.68
Cash & Short-Term Investments	559.47	628.11	879.52	526.42	339.15	438.68
Cash Growth	-29.45%	-28.59%	67.07%	55.22%	-22.69%	222.58%
Accounts Receivable	-	-	-	-	2.05	1
Other Receivables	40.92	35.59	35.65	24.04	19.16	10.91
Total Trade Receivables	40.92	35.59	35.65	24.04	21.21	11.91
Other Current Assets	18.74	19.18	13.43	11.41	9.02	7.97
Total Current Assets	619.14	682.89	928.61	561.87	369.38	458.56
Net Property, Plant & Equipment	20.27	21.91	17.19	27.68	32.77	17.79
Other Long-Term Assets	12.99	12.81	11.07	5.79	8.46	3.45
Total Assets	652.4	717.6	956.87	595.34	410.61	479.79
Accounts Payable	5.97	9.67	15.79	13.05	6.47	2.72
Accrued Expenses	40.12	44.35	41.25	31.51	26.45	14.24
Unearned Revenue	2.8	2.96	10.19	24.98	20.42	19.27
Total Current Liabilities	48.89	56.98	67.23	69.54	53.34	36.24
Long-Term Debt	-	-	-	30.7	30.32	29.87
Long-Term Leases	13.87	14.1	3.99	9.38	10.89	12.08
Other Long-Term Liabilities	35.31	36.54	92.59	114.8	45.28	55.35
Total Long-Term Liabilities	49.19	50.64	96.58	154.88	86.48	97.3
Total Liabilities	98.08	107.62	163.81	224.41	139.83	133.54
Common Stock	0.9	0.89	0.89	0.55	0.39	0.38
Additional Paid-in Capital	1,519	1,512	1,473	883.45	601.11	567.64
Accumulated Other Comprehensive Income	-5.28	-3.51	0.12	-1.3	0.39	-3.39
Retained Earnings	-960.58	-899.75	-680.79	-511.76	-331.1	-218.38
Shareholders' Equity	554.32	609.98	793.06	370.93	270.78	346.25
Total Liabilities & Equity	652.4	717.6	956.87	595.34	410.61	479.79
Total Debt	13.87	14.1	3.99	40.08	41.2	41.95
Net Cash (Debt)	545.6	614.01	875.53	486.34	297.95	396.73
Net Cash Growth	-11.14%	-29.87%	80.02%	63.23%	-24.90%	227.71%
Net Cash Per Share	7.86	8.86	15.04	13.66	10.04	15.83
Book Value	554.32	609.98	793.06	370.93	270.78	346.25
Book Value Per Share	7.99	8.80	13.62	10.42	9.13	13.82
Tangible Book Value	554.32	609.98	793.06	370.93	270.78	346.25
Tangible Book Value Per Share	7.99	8.80	13.62	10.42	9.13	13.82